UPDATE 2-AbbVie, AndroGel partner owe $448 million in antitrust case -U.S. judge
June 29, 2018 at 21:37 PM EDT
June 29 (Reuters) - A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic versions of testosterone replacement drug AndroGel from getting to market and ordered the drugmaker and its partner to pay $448 million.
